Management of Positive PPD Test Results

Initial Evaluation and Diagnosis

The Centers for Disease Control and Prevention recommends that all individuals with newly recognized positive PPD test results should be promptly evaluated for active tuberculosis through a clinical examination and chest radiograph 1, 3, 4
If the history, clinical examination, or chest radiograph is compatible with active TB, additional diagnostic tests should be performed, including sputum examination for acid-fast bacilli (AFB) 5, 6
Individuals with symptoms compatible with TB, such as persistent cough, bloody sputum, night sweats, weight loss, anorexia, or fever, should be excluded from workplace/normal activities until active TB is ruled out or treatment is initiated 1, 3

A PPD test result of ≥5 mm induration is considered positive for persons with HIV infection or at risk for HIV infection, recent contacts of persons with infectious TB, and persons with fibrotic changes on chest radiograph consistent with prior TB 3
The standard regimen for preventive therapy is Isoniazid (INH) 300 mg daily for adults and 10 mg/kg/day for children, with a treatment duration of 9 months for most individuals 6
Alternative regimens, such as 4 months of rifampin (600 mg/day), may be used for those who cannot tolerate INH or are exposed to INH-resistant organisms 6, 7

If active TB is diagnosed, initiate appropriate multi-drug therapy according to susceptibility patterns, and exclude the individual from workplace/normal activities until non-infectious 1, 3, 4
Document adequate therapy, resolution of cough, and three consecutive negative sputum smears before return to normal activities 1, 3
Monthly assessment for adverse reactions, particularly hepatotoxicity, is recommended during preventive therapy, with baseline transaminase measurements and monthly monitoring for persons over 35 years of age 6

For healthcare workers, document the positive PPD result in their health record and determine if it represents a conversion from a previous negative test, and investigate potential sources of exposure if conversion has occurred 1, 8
For persons with BCG vaccination history, a PPD reaction ≥10 mm is likely due to TB infection rather than BCG, especially if vaccination was in childhood and the person is from a high TB prevalence country 9
For immunocompromised individuals, consider more frequent monitoring for TB symptoms even after preventive therapy 1, 3